SCHEMBL4914030

SCHEMBL4914030

COc1ccc(CNC(=O)c2ccc(CN(C(=O)CC(C)C)C3CCN(Cc4ccc(F)cc4)CC3)cc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 10/20 0.54
TSHR P16473 1/20 0.54
OPRM1 P35372 3/20 0.52
ABCB11 O95342 1/20 0.52
CYP1A2 P05177 1/20 0.52
ADRB2 P07550 1/20 0.52
CHRM2 P08172 1/20 0.52
CHRM1 P11229 1/20 0.52
DRD1 P21728 1/20 0.52
TBXA2R P21731 1/20 0.52
SLC6A2 P23975 1/20 0.52
HTR2C P28335 1/20 0.52
GPR183 P32249 1/20 0.52
CYP2C19 P33261 1/20 0.52
ADRA1A P35348 1/20 0.52
APLNR P35414 1/20 0.52
DRD3 P35462 1/20 0.52
CX3CR1 P49238 1/20 0.52
SLC6A3 Q01959 1/20 0.52
KCNH2 Q12809 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4916458 0.91 TSHR (0.56) HTR2ATSHROPRM1ABCB11CYP1A2
SCHEMBL4922782 0.90 TSHR (0.55) HTR2ATSHROPRM1ABCB11CYP1A2
SCHEMBL4926169 0.89 TSHR (0.55) HTR2ATSHROPRM1ABCB11CYP1A2
SCHEMBL4913986 0.89 TSHR (0.54) HTR2ATSHROPRM1ABCB11CYP1A2
SCHEMBL4920750 0.88 TSHR (0.53) HTR2ATSHROPRM1ABCB11CYP1A2
SCHEMBL4923572 0.88 TSHR (0.53) HTR2ATSHROPRM1ABCB11CYP1A2
SCHEMBL4921760 0.88 TSHR (0.55) HTR2ATSHROPRM1ABCB11CYP1A2
SCHEMBL4916465 0.87 TSHR (0.56) HTR2ATSHROPRM1ABCB11CYP1A2
SCHEMBL4924366 0.86 TSHR (0.51) HTR2ATSHROPRM1ABCB11CYP1A2
SCHEMBL4924079 0.86 TSHR (0.55) HTR2ATSHROPRM1ABCB11CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080081824-A1 Substituted piperidines as modulators of chemokine receptor activity BRISTOL-MYERS SQUIBB COMPANY 2008-04-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080081824-A1 Substituted piperidines as modulators of chemokine receptor activity CCR1, CCR3, CCR2 HTR2A 1435/4885TSHR 727/4885OPRM1 154/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.